Skip to content

People
Capabilities
Main /
Capabilities
Capabilities

Antitrust

Artificial Intelligence

Business Restructuring

Corporate & Transactional

Crisis Management

Data, Privacy & Cybersecurity

Employee Benefits & Executive Compensation

Employment

Government & Lobbying Strategies

Government Contracts

Intellectual Property

International Trade

Investment Management

Litigation & Dispute Resolution

Mergers & Acquisitions

Private Client

Real Estate

Shareholder Activism

Strategic Solutions

Sustainability, Impact & ESG

Tax

Trade Secrets

White-Collar Defense & Government Investigations

Regional Markets

View all capabilities
Industries spotlight

Health & Life Sciences

Guiding health and life sciences transformation

Private Equity

Driving investment performance

Media, Entertainment & Sports

Turning creative assets into strategic value

View all
Industries
Main /
Industries
Industries

Accounting & Consulting Services

Alcohol

Digital Infrastructure

Energy & Infrastructure

Financial Services

FinTech & Blockchain

Food, Beverage & Agribusiness

Health & Life Sciences

Insurance

Media, Entertainment & Sports

Private Equity

Technology

Venture Capital & Emerging Growth

View all industries
Case studies

Zocdoc

How Zocdoc broke regulatory ground as an online healthcare resource

Doral Renewables

Doral Renewables’ drive to build sustainable solar solutions

Sustainable Procurement Pledge

Connecting the dots for supply chain sustainability

View all case studies
Insights
main /
Insights
Featured

main / Insights / Featured

Health & Life Sciences

Where MedTech is attracting PE attention with less FDA burden

White-Collar Defense

DOJ revises Justice Manual guidance on two key False Claims Act issues

Energy & Infrastructure

What the Copia Power sale signals for digital infrastructure investment

Topics

main / Insights / Topics

Private Capital

Global Privacy & Cybersecurity

Artificial Intelligence Law

US Policy Watch

View all insights
Categories

main / Insights / Categories

Articles

Client Alerts

Case Studies

Podcasts

Reports

Resources

Topics

Videos

Trending

main / Insights / Trending

Client alert DEA appears close to finalizing telemedicine special registration

Client alert 24-hour reporting deadline under the EU Cyber Resilience Act now in effect
- Articles
- Client Alerts
- Case Studies
- Podcasts
- Reports
- Resources
- Topics
- Videos
Events
Main /
Events
Upcoming events

Oct 19 – Oct 23

In-person Pepperdine’s Global Family Office Summit 2026

October 27, 2026

In-person San Francisco Private Funds Roundtable & Cocktail Reception

Oct 29

Virtual 340B: Back to Basics

Oct 22

Virtual Canary Forum 2026

Oct 27

Virtual Cybersecurity Risks in the Workforce: Emerging Threats and Employer Response

Nov 3

Virtual Managing Legal Risk in AI-Driven Employment Decisions

View all events
Featured

In-person

Life Sciences Investment Forum 2026

In-person

HPE Miami 2027
Careers

- English
- Deutsch
- Français
- Italiano

See all results for >

Newsroom Categories: Coverage

MCN Investments’ $30 Million Financing

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

MCN Investments’ $30 Million Financing

April 22, 2024

Read time: 2 min

About Us

Related people

Howard Kleinman

Partner

New York – One Vanderbilt Avenue

Michael L. Boykins

Partner

Chicago

Stephen Pedersen

Partner

Miami

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Corporate & Transactional United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
Blocked JetBlue-Spirit Deal Illustrates New Antitrust Approach

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Blocked JetBlue-Spirit Deal Illustrates New Antitrust Approach

April 19, 2024

Read time: 2 min

About Us

Related people

Lisa P. Rumin

Partner

Washington, DC

Anthony S. Ferrara

Partner

Washington, DC

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Antitrust United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
Royalty Rates

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Royalty Rates

April 19, 2024

Read time: 2 min

About Us

Related people

Amol Parikh

Partner

Chicago

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Intellectual Property United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
Federal Circuit Report

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Federal Circuit Report

April 19, 2024

Read time: 2 min

About Us

Related people

Benjamin N. Ediger, PhD

Associate

Austin

Amol Parikh

Partner

Chicago

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Intellectual Property United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
How I Deal With Stress: A Mcdermott Partner On Setting Boundaries And The Difficulty Of Taking Time Out

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

How I Deal With Stress: A Mcdermott Partner On Setting Boundaries And The Difficulty Of Taking Time Out

April 22, 2024

Read time: 2 min

Private equity partner Fatema Orjela was quoted in Law.com International in relation to their series on how senior corporate lawyers cope with the pressures of both their work and personal lives. Fatema discusses how she has juggled motherhood with her career, and the importance of not ‘bottling up’ your feelings.

About Us

Related people

Fatema Orjela

Partner

London – 22 Bishopsgate

You may also like

Coverage

Deloitte’s 2026 Global Divestiture Survey

Coverage

Explained: UK fund managers face post-Brexit regulatory shake-up, Finextra

Coverage

Private equity investment in APAC health care facilities exceeds 2025 total, S&P Global Market Intelligence

Related

Private Equity United Kingdom

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
Refreshed Drug Discount Dispute Process to Face Wave of Claims

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Refreshed Drug Discount Dispute Process to Face Wave of Claims

April 22, 2024

Read time: 2 min

About Us

Related people

Emily Jane Cook

Partner

Los Angeles, Washington, DC

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
Medicare Advantage Fight Shifts to 340B Arena

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Medicare Advantage Fight Shifts to 340B Arena

April 22, 2024

Read time: 2 min

About Us

Related people

Emily Jane Cook

Partner

Los Angeles, Washington, DC

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
CMS Does Not Address Lump Sum Payments for 340B Hospitals in Latest Medicare Advantage Policies but Might in 2025

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

CMS Does Not Address Lump Sum Payments for 340B Hospitals in Latest Medicare Advantage Policies but Might in 2025

April 18, 2024

Read time: 2 min

About Us

Related people

Emily Jane Cook

Partner

Los Angeles, Washington, DC

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
Favorable Winds Despite Challenges, Offshore Wind Projects are Moving Forward Across New England

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Favorable Winds Despite Challenges, Offshore Wind Projects are Moving Forward Across New England

April 18, 2024

Read time: 2 min

About Us

Related people

Christopher Gladbach

Partner

Washington, DC

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Corporate & Transactional Energy & Infrastructure United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 22, 2024
Healthcare Merger Deals Carefully Tread New Antitrust Terrain

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Healthcare Merger Deals Carefully Tread New Antitrust Terrain

April 19, 2024

Read time: 2 min

About Us

Related people

John M. Callahan

Partner

Chicago

You may also like

Virtual

Enforcement Outlook | Key takeaways: Healthcare Litigation, Compliance, and Investigation Trends 

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

April 19, 2024

←Previous Page

1 … 119 120 121 122 123 … 349

Firm

About
Offices
Newsroom
Alumni
Careers

Sign In

McDermott Access

Related Sites

Farragut Square Group

Connect

Contact
Subscribe

ALWAYS BETTER

Legal Notices/Imprint
Privacy Policy
Terms of Use
Sitemap

Attorney advertising © 2026 McDermott Will & Schulte

Disclaimer

Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.